Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Orchard Therapeutics plc | Chief Executive Officer, Director | Ordinary Shares | 0 | $0.46 | Jan 24, 2024 | Direct | |
Orchard Therapeutics plc | Chief Executive Officer, Director | Stock Option (Right to Buy) | 0 | Jan 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ORTX | Orchard Therapeutics plc | Jan 24, 2024 | 13 | $0 | 4 | Jan 24, 2024 | Chief Executive Officer, Director |
ORTX | Orchard Therapeutics plc | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Chief Executive Officer, Director |
ORTX | Orchard Therapeutics plc | Oct 4, 2022 | 10 | $0 | 4 | Oct 6, 2022 | Chief Executive Officer, Director |
ORTX | Orchard Therapeutics plc | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Chief Executive Officer, Director |
ORTX | Orchard Therapeutics plc | Apr 1, 2022 | 1 | $11.1K | 4 | Apr 5, 2022 | Chief Executive Officer, Director |